Skip to main content
. Author manuscript; available in PMC: 2012 Oct 18.
Published in final edited form as: Drug Dev Res. 1996 Sep 1;39(1):36–46. doi: 10.1002/(sici)1098-2299(19960901)39:1<36::aid-ddr5>3.0.co;2-l

Figure 6.

Figure 6

Elevation of intracellular calcium levels by NECA and 2-CI-IBMECA in RBL-2H3 mast cells. Effects of the selective A3- adenosine receptor antagonist MRS 1067. Cells were prelabeled with fura-2 as described in Methods. Additions (arrows) were as follows: A: NECA, 1 µM; B: 2-CI-IBMECA, 1 µM; C: NECA plus MRS 1067, 30 µM. D. 2-CI-IBMECA plus MRS 1067, 30 µM.